CEFADROXIL

CEFADROXIL was reported 2034 times

CEFADROXIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERSPLENISM ACQUIRED 2 0.2857
1 URTICARIA THERMAL 20 0.1408
2 NASAL OEDEMA 217 0.1200
3 VEILLONELLA INFECTION 3 0.1200
4 THERAPEUTIC PRODUCT CROSS-REACTIVITY 46 0.0515
5 ADMINISTRATION SITE ERYTHEMA 14 0.0491
6 SPINAL CORD INJURY LUMBAR 3 0.0448
7 MAMMARY DUCT ECTASIA 2 0.0444
8 HEALTH ASSESSMENT QUESTIONNAIRE SCORE INCREASED 4 0.0385
9 AGITATION POSTOPERATIVE 2 0.0317
10 HERNIA CONGENITAL 2 0.0290
11 ANTICOAGULANT-RELATED NEPHROPATHY 4 0.0253
12 STOMATOCOCCAL INFECTION 3 0.0242
13 SALMONELLA BACTERAEMIA 5 0.0242
14 IODINE ALLERGY 8 0.0240
15 INFLUENZA VIRUS TEST POSITIVE 5 0.0237
16 NEISSERIA INFECTION 3 0.0236
17 DISABILITY ASSESSMENT SCALE SCORE INCREASED 6 0.0195
18 PNEUMONIA HAEMOPHILUS 9 0.0185
19 EAR INFECTION FUNGAL 5 0.0166
20 BACILLARY ANGIOMATOSIS 2 0.0147
21 WOUND INFECTION PSEUDOMONAS 4 0.0127
22 ANAEMIA OF PREGNANCY 2 0.0116
23 BACTEROIDES INFECTION 3 0.0115
24 AEROMONAS INFECTION 2 0.0106
25 CROSS SENSITIVITY REACTION 9 0.0092
26 ANAEMIA NEONATAL 4 0.0083
27 RESPIRATORY TRACT INFECTION 213 0.0082
28 PLANTAR ERYTHEMA 2 0.0081
29 METASTATIC MALIGNANT MELANOMA 18 0.0078
30 LEUKAEMOID REACTION 2 0.0077
31 VENOUS INSUFFICIENCY 5 0.0069
32 MENINGISM 3 0.0064
33 ORGASM ABNORMAL 5 0.0062
34 IMMUNODEFICIENCY COMMON VARIABLE 3 0.0061
35 ABDOMINOPLASTY 2 0.0060
36 DERMOID CYST 2 0.0060
37 CHEST WALL PAIN 2 0.0060
38 NEPHROGENIC ANAEMIA 27 0.0058
39 GINGIVAL ERYTHEMA 5 0.0058
40 HYPERPARATHYROIDISM SECONDARY 14 0.0056
41 CORONARY ARTERY INSUFFICIENCY 2 0.0056
42 KERATOCONJUNCTIVITIS SICCA 2 0.0054
43 ENTEROCOLITIS INFECTIOUS 5 0.0054
44 BREAST RECONSTRUCTION 2 0.0053
45 REBOUND ACID HYPERSECRETION 16 0.0053
46 VITAMIN B12 DEFICIENCY 21 0.0052
47 PNEUMOCOCCAL INFECTION 3 0.0051
48 CAT SCRATCH DISEASE 2 0.0050
49 DYSBIOSIS 4 0.0049
50 GASTROINTESTINAL ANGIODYSPLASIA 2 0.0049
51 URETEROLITHIASIS 5 0.0048
52 SUPERFICIAL VEIN THROMBOSIS 4 0.0048
53 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
54 GALLBLADDER CHOLESTEROLOSIS 2 0.0044
55 IMMUNE-MEDIATED LUNG DISEASE 8 0.0044
56 TYPE IV HYPERSENSITIVITY REACTION 12 0.0044
57 NECROSIS ISCHAEMIC 2 0.0043
58 PYOGENIC GRANULOMA 2 0.0043
59 URINE LEUKOCYTE ESTERASE POSITIVE 3 0.0043
60 GROIN ABSCESS 5 0.0042
61 ELECTROCARDIOGRAM ST-T CHANGE 3 0.0042
62 OEDEMA 228 0.0042
63 COARCTATION OF THE AORTA 4 0.0041
64 FRACTURED SACRUM 5 0.0040
65 CORONAVIRUS TEST POSITIVE 4 0.0039
66 GUTTATE PSORIASIS 3 0.0037
67 FUNGAL SEPSIS 3 0.0036
68 WHEEZING 211 0.0036
69 PROTRUSION TONGUE 2 0.0034
70 ORTHOSTATIC HYPERTENSION 2 0.0034
71 PIGMENTATION DISORDER 20 0.0032
72 MONOCYTOSIS 2 0.0032
73 FORCED VITAL CAPACITY DECREASED 2 0.0031
74 MENISCUS LESION 4 0.0029
75 SKIN PLAQUE 24 0.0028
76 BONE DEMINERALISATION 3 0.0028
77 PCO2 INCREASED 2 0.0028
78 BLOOD PRESSURE DIASTOLIC ABNORMAL 7 0.0027
79 FINGER AMPUTATION 2 0.0027
80 NORMOCYTIC ANAEMIA 4 0.0027
81 PELVIC ABSCESS 3 0.0026
82 BLOOD PRESSURE DIASTOLIC INCREASED 12 0.0026
83 EXCESSIVE GRANULATION TISSUE 2 0.0025
84 INTERVERTEBRAL DISC SPACE NARROWING 2 0.0025
85 CARTILAGE ATROPHY 2 0.0025
86 CLOSTRIDIUM COLITIS 3 0.0025
87 END STAGE RENAL DISEASE 45 0.0025
88 BLOOD PRESSURE SYSTOLIC ABNORMAL 6 0.0024
89 ASTHMA 273 0.0024
90 SCRATCH 25 0.0024
91 CAROTID ARTERY DISEASE 3 0.0024
92 PROCEDURAL HYPOTENSION 2 0.0024
93 PSEUDOMONAL BACTERAEMIA 2 0.0023
94 ADENOMA BENIGN 2 0.0023
95 WOUND INFECTION STAPHYLOCOCCAL 4 0.0023
96 PERIODONTITIS 5 0.0023
97 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
98 CARDIAC OUTPUT DECREASED 2 0.0023
99 PRIMARY SEQUESTRUM 2 0.0022
100 URETERIC OBSTRUCTION 3 0.0022
101 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
102 DIZZINESS POSTURAL 21 0.0022
103 NARCOLEPSY 4 0.0021
104 NAIL INFECTION 3 0.0021
105 PCO2 DECREASED 2 0.0021
106 DEVICE RELATED THROMBOSIS 2 0.0020
107 CLOSTRIDIUM DIFFICILE COLITIS 21 0.0020
108 BRAIN STEM INFARCTION 2 0.0020
109 NEUTROPENIC COLITIS 4 0.0019
110 HYPERTRANSAMINASAEMIA 13 0.0019
111 DRY AGE-RELATED MACULAR DEGENERATION 2 0.0018
112 BACTERIAL TEST POSITIVE 4 0.0018
113 SECRETION DISCHARGE 22 0.0018
114 SPONDYLOLISTHESIS 3 0.0017
115 ARTHRITIS INFECTIVE 8 0.0017
116 INCISION SITE PAIN 2 0.0017
117 CHRONIC KIDNEY DISEASE 129 0.0017
118 BLEEDING TIME PROLONGED 2 0.0017
119 CHOLECYSTITIS CHRONIC 11 0.0016
120 OTITIS EXTERNA 2 0.0016
121 BLADDER PROLAPSE 2 0.0016
122 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
123 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
124 LYMPH NODE PAIN 3 0.0016
125 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
126 HYPERAESTHESIA TEETH 2 0.0016
127 FACE INJURY 6 0.0016
128 PACKED RED BLOOD CELL TRANSFUSION 2 0.0015
129 NEPHRITIS 5 0.0015
130 HIP SURGERY 8 0.0015
131 AGORAPHOBIA 2 0.0015
132 IMMUNOGLOBULINS DECREASED 2 0.0015
133 CHEST PAIN 257 0.0014
134 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35 0.0014
135 TOOTH DISCOLOURATION 4 0.0014
136 GINGIVAL SWELLING 6 0.0014
137 ECONOMIC PROBLEM 20 0.0013
138 LICHENOID KERATOSIS 3 0.0013
139 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 2 0.0013
140 PNEUMONIA PSEUDOMONAL 2 0.0013
141 FIBROSIS 4 0.0013
142 PANIC DISORDER 5 0.0013
143 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
144 PATELLA FRACTURE 3 0.0013
145 OSTEOSCLEROSIS 2 0.0013
146 INTERMITTENT CLAUDICATION 2 0.0013
147 PITUITARY TUMOUR BENIGN 2 0.0012
148 PERIPHERAL ISCHAEMIA 5 0.0012
149 LINEAR IGA DISEASE 2 0.0012
150 MITRAL VALVE PROLAPSE 2 0.0012
151 ENTEROBACTER INFECTION 2 0.0012
152 WOUND DEHISCENCE 4 0.0012
153 EXPOSURE TO SARS-COV-2 2 0.0012
154 LAZINESS 2 0.0012
155 SKIN INFECTION 13 0.0012
156 HERNIA REPAIR 3 0.0012
157 MASTECTOMY 2 0.0011
158 FANCONI SYNDROME ACQUIRED 2 0.0011
159 EXFOLIATIVE RASH 3 0.0011
160 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
161 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
162 SCLERODERMA 4 0.0011
163 ESSENTIAL HYPERTENSION 2 0.0011
164 CELLULITIS 55 0.0011
165 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
166 LOBAR PNEUMONIA 2 0.0011
167 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
168 PSYCHOMOTOR RETARDATION 3 0.0011
169 VAGINAL INFECTION 5 0.0011
170 WALKING AID USER 7 0.0011
171 INFECTED SKIN ULCER 2 0.0011
172 JAUNDICE NEONATAL 2 0.0011
173 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
174 HYPERTONIC BLADDER 3 0.0010
175 LOCALISED INFECTION 25 0.0010
176 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 8 0.0010
177 EPIGASTRIC DISCOMFORT 4 0.0010
178 NECK INJURY 3 0.0010
179 COLOSTOMY 2 0.0010
180 JOINT EFFUSION 7 0.0010
181 PLEURISY 6 0.0010
182 BLADDER DISORDER 10 0.0010
183 WOUND INFECTION 11 0.0010
184 HEPATIC ENZYME ABNORMAL 5 0.0010
185 POST PROCEDURAL INFECTION 8 0.0010
186 NEPHROPATHY 9 0.0010
187 PHARYNGOLARYNGEAL PAIN 5 0.0009
188 COUGH 263 0.0009
189 ATELECTASIS 9 0.0009
190 PNEUMONIA 301 0.0009
191 ANGINA UNSTABLE 6 0.0009
192 EXPOSED BONE IN JAW 2 0.0009
193 ANHEDONIA 24 0.0009
194 OTITIS MEDIA 3 0.0009
195 NOSOCOMIAL INFECTION 2 0.0009
196 NOCTURIA 11 0.0009
197 STREPTOCOCCAL INFECTION 5 0.0009
198 RENAL CYST 7 0.0009
199 PERIARTHRITIS 2 0.0009
200 ORAL PRURITUS 2 0.0009
201 LICHEN PLANUS 2 0.0009
202 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
203 DERMATITIS BULLOUS 6 0.0008
204 ENTEROCOCCAL INFECTION 4 0.0008
205 OSTEOARTHRITIS 35 0.0008
206 GLOMERULONEPHRITIS 2 0.0008
207 RENAL TUBULAR NECROSIS 8 0.0008
208 BODY TEMPERATURE DECREASED 8 0.0008
209 GRIP STRENGTH DECREASED 7 0.0008
210 MULTIPLE INJURIES 5 0.0008
211 DRY THROAT 8 0.0008
212 PHLEBITIS 4 0.0008
213 BLOOD CHLORIDE DECREASED 2 0.0008
214 TRISMUS 4 0.0008
215 LIPOMA 2 0.0008
216 HEPATOTOXICITY 17 0.0008
217 AREFLEXIA 2 0.0007
218 DEFORMITY 7 0.0007
219 BLEPHARITIS 3 0.0007
220 SKIN CANCER 16 0.0007
221 HAEMATOMA 19 0.0007
222 POLYURIA 6 0.0007
223 ORAL FUNGAL INFECTION 2 0.0007
224 ESCHERICHIA INFECTION 6 0.0007
225 HYPERKERATOSIS 4 0.0007
226 HYPOMAGNESAEMIA 10 0.0007
227 PROCTITIS 2 0.0007
228 ACUTE KIDNEY INJURY 109 0.0007
229 NEUTROPHIL COUNT ABNORMAL 2 0.0007
230 NECK MASS 2 0.0007
231 CHOLECYSTITIS ACUTE 4 0.0007
232 DIVERTICULUM 5 0.0007
233 PRODUCT SUPPLY ISSUE 5 0.0007
234 OVARIAN CYST 7 0.0007
235 SPINAL OSTEOARTHRITIS 6 0.0007
236 TOOTH INFECTION 9 0.0007
237 ORAL DISORDER 5 0.0007
238 RHINITIS ALLERGIC 3 0.0007
239 RENAL FAILURE 89 0.0007
240 URINARY TRACT DISORDER 3 0.0007
241 OSTEOPENIA 10 0.0007
242 CHEST X-RAY ABNORMAL 2 0.0007
243 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
244 CARDIOMEGALY 8 0.0006
245 PORTAL HYPERTENSION 2 0.0006
246 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
247 DIASTOLIC DYSFUNCTION 2 0.0006
248 PHARYNGITIS STREPTOCOCCAL 7 0.0006
249 BASAL CELL CARCINOMA 10 0.0006
250 ARTERIOSCLEROSIS 6 0.0006
251 SPINAL DISORDER 6 0.0006
252 BREAST CANCER RECURRENT 2 0.0006
253 SPUTUM DISCOLOURED 6 0.0006
254 NON-CARDIAC CHEST PAIN 2 0.0006
255 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
256 GINGIVAL PAIN 5 0.0006
257 SUBCUTANEOUS ABSCESS 3 0.0006
258 HIATUS HERNIA 8 0.0006
259 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
260 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
261 PAIN 377 0.0006
262 RENAL CELL CARCINOMA 3 0.0006
263 NODULE 8 0.0006
264 VOMITING 287 0.0006
265 SPRUE-LIKE ENTEROPATHY 3 0.0006
266 INFUSION SITE HAEMORRHAGE 2 0.0006
267 ORAL CANDIDIASIS 8 0.0006
268 HYPERVOLAEMIA 3 0.0006
269 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
270 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
271 DERMATITIS EXFOLIATIVE 3 0.0006
272 PROSTATE CANCER METASTATIC 2 0.0006
273 ATRIAL SEPTAL DEFECT 5 0.0006
274 ERYSIPELAS 3 0.0006
275 BLOOD BILIRUBIN INCREASED 16 0.0006
276 POSTOPERATIVE WOUND INFECTION 4 0.0006
277 MALAISE 259 0.0006
278 HIP ARTHROPLASTY 9 0.0006
279 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
280 FACIAL PARALYSIS 5 0.0006
281 HYPERLIPIDAEMIA 7 0.0006
282 RASH MACULO-PAPULAR 13 0.0006
283 BRONCHOPNEUMONIA 2 0.0006
284 PERIPHERAL VASCULAR DISORDER 3 0.0006
285 VARICOSE VEIN 3 0.0006
286 LYMPHOEDEMA 4 0.0006
287 VENTRICULAR EXTRASYSTOLES 6 0.0006
288 STAPHYLOCOCCAL INFECTION 19 0.0006
289 TRANSFUSION 6 0.0006
290 CAROTID ARTERY STENOSIS 2 0.0006
291 PAPULE 4 0.0006
292 RENAL PAIN 6 0.0006
293 RHINORRHOEA 36 0.0006
294 GINGIVITIS 3 0.0006
295 ANAL INCONTINENCE 5 0.0006
296 SKIN LACERATION 6 0.0006
297 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
298 MOUTH HAEMORRHAGE 4 0.0005
299 UROSEPSIS 5 0.0005
300 FOOT DEFORMITY 6 0.0005
301 BLOOD UREA INCREASED 9 0.0005
302 NERVOUSNESS 28 0.0005
303 HYDRONEPHROSIS 4 0.0005
304 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
305 LACERATION 5 0.0005
306 CHROMATURIA 12 0.0005
307 SARS-COV-2 TEST POSITIVE 7 0.0005
308 LIVER INJURY 13 0.0005
309 CORONARY ARTERY BYPASS 3 0.0005
310 DYSPNOEA 295 0.0005
311 NEOPLASM PROGRESSION 18 0.0005
312 RALES 3 0.0005
313 ACUTE HEPATIC FAILURE 7 0.0005
314 ANAPHYLACTIC REACTION 28 0.0005
315 CATARACT OPERATION 3 0.0005
316 GALLBLADDER DISORDER 9 0.0005
317 PATENT DUCTUS ARTERIOSUS 2 0.0005
318 CHOLECYSTITIS 6 0.0005
319 TRICUSPID VALVE INCOMPETENCE 4 0.0005
320 SKIN ULCER 13 0.0005
321 CEREBRAL ATROPHY 2 0.0005
322 AZOTAEMIA 2 0.0005
323 CANDIDIASIS 2 0.0005
324 OSTEOMYELITIS 9 0.0005
325 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
326 ARTHRITIS BACTERIAL 2 0.0005
327 GENERALISED OEDEMA 6 0.0005
328 FLUID OVERLOAD 7 0.0005
329 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
330 FOOT FRACTURE 9 0.0005
331 RENAL INJURY 14 0.0005
332 ABSCESS LIMB 2 0.0005
333 PURULENT DISCHARGE 2 0.0005
334 PSEUDOMONAS INFECTION 4 0.0005
335 ABNORMAL SENSATION IN EYE 2 0.0005
336 METASTATIC NEOPLASM 2 0.0005
337 BLOOD MAGNESIUM DECREASED 4 0.0005
338 MUSCLE STRAIN 4 0.0005
339 OCULAR ICTERUS 2 0.0005
340 TENDON DISORDER 3 0.0005
341 BACK INJURY 5 0.0005
342 SOMNAMBULISM 3 0.0005
343 MELANOCYTIC NAEVUS 2 0.0005
344 GASTROINTESTINAL PAIN 5 0.0005
345 BLOOD CREATINE INCREASED 2 0.0005
346 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
347 PAPILLOEDEMA 2 0.0004
348 NASAL CONGESTION 26 0.0004
349 TOOTHACHE 8 0.0004
350 MITRAL VALVE INCOMPETENCE 5 0.0004
351 BODY TEMPERATURE INCREASED 9 0.0004
352 INJURY 31 0.0004
353 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
354 ULCER 7 0.0004
355 HIDRADENITIS 4 0.0004
356 DERMATITIS CONTACT 5 0.0004
357 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
358 MADAROSIS 5 0.0004
359 EXTRASYSTOLES 3 0.0004
360 POST PROCEDURAL HAEMORRHAGE 5 0.0004
361 WOUND 12 0.0004
362 ERYTHEMA MULTIFORME 4 0.0004
363 BACTERIAL INFECTION 8 0.0004
364 CHOLELITHIASIS 14 0.0004
365 FLANK PAIN 4 0.0004
366 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
367 SEASONAL ALLERGY 6 0.0004
368 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
369 BACTERAEMIA 5 0.0004
370 OROPHARYNGEAL PAIN 39 0.0004
371 SINUSITIS 43 0.0004
372 GASTRITIS 11 0.0004
373 HYPOVOLAEMIC SHOCK 2 0.0004
374 BLOOD PRESSURE FLUCTUATION 10 0.0004
375 FAECAL INCONTINENCE 2 0.0004
376 NEPHROLITHIASIS 19 0.0004
377 GUILLAIN-BARRE SYNDROME 2 0.0004
378 GASTROINTESTINAL DISORDER 37 0.0004
379 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
380 GASTROENTERITIS 6 0.0004
381 CHILLS 48 0.0004
382 SCAR 7 0.0004
383 URINARY INCONTINENCE 12 0.0004
384 TENDON RUPTURE 5 0.0004
385 LIMB INJURY 11 0.0004
386 STEVENS-JOHNSON SYNDROME 9 0.0004
387 DIABETIC NEUROPATHY 2 0.0004
388 ANEURYSM 2 0.0004
389 UPPER LIMB FRACTURE 8 0.0004
390 HYPERNATRAEMIA 2 0.0004
391 HEART RATE DECREASED 14 0.0004
392 HEART RATE IRREGULAR 9 0.0004
393 CORONARY ARTERY STENOSIS 2 0.0004
394 ARTHROPATHY 22 0.0004
395 HEAD DISCOMFORT 7 0.0004
396 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
397 BOWEL MOVEMENT IRREGULARITY 3 0.0004
398 SEPTIC SHOCK 17 0.0004
399 ENDOCARDITIS 2 0.0004
400 RIB FRACTURE 8 0.0004
401 INFLAMMATION 20 0.0004
402 DEEP VEIN THROMBOSIS 25 0.0004
403 GASTROINTESTINAL INFLAMMATION 3 0.0004
404 FOLLICULITIS 4 0.0004
405 KNEE ARTHROPLASTY 8 0.0004
406 BLOOD LACTIC ACID INCREASED 2 0.0004
407 POLYARTHRITIS 2 0.0004
408 FURUNCLE 3 0.0004
409 ANORECTAL DISCOMFORT 2 0.0004
410 LEARNING DISABILITY 2 0.0004
411 INFECTION 54 0.0004
412 STENT PLACEMENT 3 0.0004
413 MUSCLE DISORDER 3 0.0004
414 PRESYNCOPE 9 0.0004
415 CHEILITIS 2 0.0004
416 ERYTHEMA OF EYELID 2 0.0004
417 OEDEMA PERIPHERAL 45 0.0004
418 FAECES DISCOLOURED 8 0.0004
419 BIPOLAR DISORDER 4 0.0004
420 IMPAIRED HEALING 12 0.0004
421 JAW DISORDER 2 0.0004
422 OSTEOPOROSIS 15 0.0004
423 HAIR DISORDER 3 0.0004
424 CORONARY ARTERY DISEASE 11 0.0004
425 DIVERTICULITIS 10 0.0004
426 CARPAL TUNNEL SYNDROME 5 0.0004
427 ACUTE PULMONARY OEDEMA 2 0.0004
428 OCULAR DISCOMFORT 4 0.0004
429 BLOOD TEST ABNORMAL 5 0.0004
430 INFUSION SITE ERYTHEMA 3 0.0004
431 URTICARIA 59 0.0004
432 PERONEAL NERVE PALSY 2 0.0004
433 BONE DENSITY DECREASED 11 0.0004
434 DRUG RESISTANCE 9 0.0004
435 CHOLECYSTECTOMY 4 0.0003
436 ANAPHYLACTIC SHOCK 9 0.0003
437 CARDIAC MURMUR 3 0.0003
438 BLOOD URIC ACID INCREASED 2 0.0003
439 GROIN PAIN 3 0.0003
440 ILLNESS 35 0.0003
441 DECREASED INTEREST 2 0.0003
442 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
443 DRUG ERUPTION 6 0.0003
444 CARDIOMYOPATHY 5 0.0003
445 BLOOD IRON DECREASED 4 0.0003
446 FACIAL PAIN 3 0.0003
447 URINARY TRACT INFECTION 57 0.0003
448 BONE LOSS 5 0.0003
449 LEUKOCYTOSIS 6 0.0003
450 HALLUCINATION, VISUAL 7 0.0003
451 ERYTHEMA 68 0.0003
452 BONE DISORDER 6 0.0003
453 INSURANCE ISSUE 5 0.0003
454 MENISCUS INJURY 2 0.0003
455 IRON DEFICIENCY ANAEMIA 3 0.0003
456 DEVICE RELATED INFECTION 5 0.0003
457 BRONCHITIS 24 0.0003
458 MUSCULOSKELETAL CHEST PAIN 5 0.0003
459 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
460 AGRANULOCYTOSIS 6 0.0003
461 CHOLANGITIS 2 0.0003
462 ILEUS 4 0.0003
463 OXYGEN SATURATION DECREASED 18 0.0003
464 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
465 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
466 PHOTOPHOBIA 6 0.0003
467 SQUAMOUS CELL CARCINOMA 3 0.0003
468 INFUSION SITE SWELLING 2 0.0003
469 BLEPHAROSPASM 2 0.0003
470 SLEEP APNOEA SYNDROME 6 0.0003
471 HYPERKALAEMIA 11 0.0003
472 SCIATICA 5 0.0003
473 ABSCESS 5 0.0003
474 ORAL PAIN 7 0.0003
475 POST PROCEDURAL COMPLICATION 6 0.0003
476 HAEMOGLOBIN ABNORMAL 2 0.0003
477 HYPERCHOLESTEROLAEMIA 3 0.0003
478 INFUSION SITE PAIN 4 0.0003
479 ANOREXIA 4 0.0003
480 EAR PAIN 6 0.0003
481 HEPATITIS ACUTE 2 0.0003
482 HAEMORRHOIDS 6 0.0003
483 EMOTIONAL DISTRESS 37 0.0003
484 POLYP 2 0.0003
485 KNEE OPERATION 3 0.0003
486 INFLUENZA 34 0.0003
487 HYPOGAMMAGLOBULINAEMIA 2 0.0003
488 MIGRAINE 29 0.0003
489 MENINGITIS 2 0.0003
490 BRONCHIECTASIS 2 0.0003
491 METASTASES TO LYMPH NODES 2 0.0003
492 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
493 TOOTH ABSCESS 3 0.0003
494 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
495 LIVER DISORDER 13 0.0003
496 NEUTROPHIL COUNT INCREASED 3 0.0003
497 ARTHRITIS 23 0.0003
498 ECCHYMOSIS 2 0.0003
499 CORONARY ARTERY OCCLUSION 4 0.0003
500 SURGERY 17 0.0003
501 TOOTH LOSS 6 0.0003
502 LARGE INTESTINE PERFORATION 2 0.0003
503 FIBROMYALGIA 7 0.0003
504 DRUG-INDUCED LIVER INJURY 9 0.0003
505 DERMATITIS 6 0.0003
506 EOSINOPHILIA 5 0.0003
507 MOUTH ULCERATION 6 0.0003
508 INCONTINENCE 3 0.0003
509 LYMPHOCYTE COUNT DECREASED 5 0.0003
510 SINUS TACHYCARDIA 4 0.0003
511 LEUKOPENIA 14 0.0003
512 BACK PAIN 65 0.0003
513 RECTAL HAEMORRHAGE 12 0.0003
514 GOUT 5 0.0003
515 HERPES ZOSTER 16 0.0003
516 DECREASED ACTIVITY 3 0.0003
517 ANAEMIA 53 0.0003
518 ARRHYTHMIA 13 0.0003
519 PRODUCTIVE COUGH 13 0.0003
520 BLINDNESS TRANSIENT 2 0.0003
521 DENTAL CARIES 3 0.0003
522 MEDICAL DEVICE COMPLICATION 2 0.0003
523 TRANSAMINASES INCREASED 6 0.0003
524 NERVE INJURY 3 0.0003
525 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
526 CONJUNCTIVITIS 5 0.0003
527 FISTULA 3 0.0003
528 MYALGIA 45 0.0003
529 INJECTION SITE BRUISING 21 0.0003
530 HEPATOCELLULAR CARCINOMA 2 0.0003
531 SKIN DISCOLOURATION 12 0.0003
532 GLAUCOMA 5 0.0003
533 ELECTROLYTE IMBALANCE 3 0.0003
534 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
535 HYPOALBUMINAEMIA 2 0.0003
536 ATRIAL FIBRILLATION 25 0.0003
537 SPLENOMEGALY 3 0.0003
538 MULTIPLE ALLERGIES 2 0.0003
539 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
540 AFFECTIVE DISORDER 2 0.0003
541 LYMPHADENOPATHY 9 0.0003
542 PRODUCT USE COMPLAINT 4 0.0003
543 PULMONARY EMBOLISM 24 0.0003
544 MENTAL STATUS CHANGES 7 0.0003
545 BLOOD PRESSURE ABNORMAL 5 0.0003
546 ATRIAL FLUTTER 2 0.0003
547 BLOOD DISORDER 2 0.0002
548 NASOPHARYNGITIS 46 0.0002
549 INJECTION SITE REACTION 17 0.0002
550 MUSCLE TIGHTNESS 4 0.0002
551 PLEURAL EFFUSION 15 0.0002
552 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
553 DECUBITUS ULCER 2 0.0002
554 SPINAL OPERATION 3 0.0002
555 MULTIPLE FRACTURES 4 0.0002
556 HYPERCALCAEMIA 3 0.0002
557 OSTEONECROSIS OF JAW 6 0.0002
558 HAIR COLOUR CHANGES 3 0.0002
559 TOOTH EXTRACTION 3 0.0002
560 FUNGAL INFECTION 8 0.0002
561 EOSINOPHIL COUNT INCREASED 2 0.0002
562 DYSPHONIA 14 0.0002
563 UNEVALUABLE EVENT 18 0.0002
564 CANDIDA INFECTION 4 0.0002
565 CATARACT 14 0.0002
566 RETCHING 5 0.0002
567 IMPAIRED WORK ABILITY 5 0.0002
568 PERIPHERAL SWELLING 36 0.0002
569 ROTATOR CUFF SYNDROME 3 0.0002
570 GENERAL PHYSICAL HEALTH DETERIORATION 27 0.0002
571 PLATELET COUNT INCREASED 3 0.0002
572 ECZEMA 12 0.0002
573 EMOTIONAL DISORDER 7 0.0002
574 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
575 FEBRILE NEUTROPENIA 15 0.0002
576 PURPURA 2 0.0002
577 SWELLING 21 0.0002
578 HAIR TEXTURE ABNORMAL 3 0.0002
579 MALIGNANT MELANOMA 3 0.0002
580 JOINT RANGE OF MOTION DECREASED 3 0.0002
581 QUALITY OF LIFE DECREASED 3 0.0002
582 THROMBOCYTOPENIA 25 0.0002
583 GASTROINTESTINAL INFECTION 2 0.0002
584 HEAVY MENSTRUAL BLEEDING 2 0.0002
585 GASTROENTERITIS VIRAL 4 0.0002
586 PELVIC PAIN 4 0.0002
587 HEPATIC ENZYME INCREASED 15 0.0002
588 RESTLESS LEGS SYNDROME 4 0.0002
589 PRODUCT AVAILABILITY ISSUE 5 0.0002
590 PANIC ATTACK 8 0.0002
591 EXOSTOSIS 2 0.0002
592 BRAIN NEOPLASM 2 0.0002
593 RESPIRATORY DISTRESS 6 0.0002
594 INCREASED TENDENCY TO BRUISE 2 0.0002
595 DYSURIA 8 0.0002
596 OVARIAN CANCER 2 0.0002
597 NERVE COMPRESSION 2 0.0002
598 PRURITUS 83 0.0002
599 NECK PAIN 12 0.0002
600 MASS 3 0.0002
601 BLOOD CREATININE INCREASED 14 0.0002
602 ANXIETY 61 0.0002
603 BLISTER 12 0.0002
604 DYSPEPSIA 21 0.0002
605 SKIN EXFOLIATION 18 0.0002
606 DISCOMFORT 13 0.0002
607 TARDIVE DYSKINESIA 6 0.0002
608 HOT FLUSH 16 0.0002
609 BLOOD SODIUM DECREASED 4 0.0002
610 RED BLOOD CELL COUNT DECREASED 6 0.0002
611 ABDOMINAL DISCOMFORT 35 0.0002
612 AFFECT LABILITY 2 0.0002
613 MENTAL DISORDER 9 0.0002
614 SKIN FISSURES 4 0.0002
615 ARTHRALGIA 85 0.0002
616 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
617 LABORATORY TEST ABNORMAL 6 0.0002
618 HOSPICE CARE 2 0.0002
619 LIGAMENT SPRAIN 2 0.0002
620 INABILITY TO AFFORD MEDICATION 2 0.0002
621 EXTRAPYRAMIDAL DISORDER 5 0.0002
622 WEIGHT DECREASED 56 0.0002
623 RESPIRATORY DISORDER 6 0.0002
624 NEUROPATHY PERIPHERAL 19 0.0002
625 BRAIN INJURY 2 0.0002
626 EMPHYSEMA 2 0.0002
627 PYREXIA 68 0.0002
628 INSOMNIA 52 0.0002
629 DEHYDRATION 26 0.0002
630 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
631 THYROID DISORDER 3 0.0002
632 ANKLE FRACTURE 3 0.0002
633 COVID-19 34 0.0002
634 HYPERTENSION 41 0.0002
635 LUNG INFECTION 3 0.0002
636 EJECTION FRACTION DECREASED 3 0.0002
637 EYE DISCHARGE 2 0.0002
638 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
639 DEAFNESS 5 0.0002
640 RENAL IMPAIRMENT 16 0.0002
641 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
642 JOINT DISLOCATION 2 0.0002
643 DRUG INTERACTION 30 0.0002
644 RESPIRATORY TRACT CONGESTION 3 0.0002
645 OBESITY 3 0.0002
646 EYE SWELLING 7 0.0002
647 EATING DISORDER 4 0.0002
648 METABOLIC ACIDOSIS 6 0.0002
649 SENSORY DISTURBANCE 3 0.0002
650 MOVEMENT DISORDER 6 0.0002
651 CARDIAC FAILURE CONGESTIVE 15 0.0002
652 PAIN IN EXTREMITY 55 0.0002
653 HIP FRACTURE 6 0.0002
654 FEAR 5 0.0002
655 INTESTINAL OBSTRUCTION 7 0.0002
656 CONFUSIONAL STATE 30 0.0002
657 HAEMOGLOBIN DECREASED 19 0.0002
658 BACK DISORDER 3 0.0002
659 DEVICE DISLOCATION 8 0.0002
660 OESOPHAGITIS 2 0.0002
661 GAIT DISTURBANCE 35 0.0002
662 ASPIRATION 2 0.0002
663 SKIN LESION 5 0.0002
664 THERAPY INTERRUPTED 13 0.0002
665 RASH 79 0.0002
666 HYPOAESTHESIA 27 0.0002
667 PROCEDURAL PAIN 5 0.0002
668 SKIN DISORDER 6 0.0002
669 TOOTH DISORDER 4 0.0002
670 DIARRHOEA 116 0.0002
671 SEPSIS 20 0.0002
672 MALNUTRITION 2 0.0002
673 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
674 THROAT IRRITATION 8 0.0002
675 ASTHENIA 67 0.0002
676 INTESTINAL PERFORATION 2 0.0002
677 BLOOD CALCIUM DECREASED 2 0.0002
678 EYE INFECTION 2 0.0002
679 DEPRESSION 40 0.0002
680 MUSCLE TWITCHING 4 0.0002
681 HYPOKALAEMIA 8 0.0002
682 LOCAL SWELLING 3 0.0002
683 LIVER FUNCTION TEST ABNORMAL 5 0.0002
684 RENAL DISORDER 8 0.0002
685 RASH MACULAR 6 0.0002
686 ACNE 13 0.0002
687 ACUTE MYOCARDIAL INFARCTION 5 0.0002
688 OCULAR HYPERAEMIA 8 0.0002
689 ATAXIA 2 0.0002
690 MYOCLONUS 2 0.0002
691 ACCIDENT 2 0.0002
692 WITHDRAWAL SYNDROME 7 0.0002
693 HEPATITIS C 2 0.0002
694 BLOOD PRESSURE DECREASED 11 0.0002
695 C-REACTIVE PROTEIN INCREASED 6 0.0002
696 ADRENAL INSUFFICIENCY 2 0.0002
697 CYTOPENIA 2 0.0002
698 HEPATIC STEATOSIS 3 0.0002
699 PANCYTOPENIA 9 0.0002
700 FATIGUE 125 0.0002
701 NERVOUS SYSTEM DISORDER 5 0.0002
702 INJECTION SITE DISCOLOURATION 2 0.0002
703 FALL 53 0.0002
704 HALLUCINATION 12 0.0002
705 FRACTURE 3 0.0002
706 BRAIN OEDEMA 2 0.0002
707 COLITIS 6 0.0002
708 ANGIOEDEMA 7 0.0002
709 ABDOMINAL PAIN LOWER 4 0.0002
710 GASTRIC CANCER 4 0.0002
711 MUSCULOSKELETAL DISORDER 3 0.0002
712 CARDIOVASCULAR DISORDER 4 0.0002
713 DIABETES MELLITUS 12 0.0002
714 WEIGHT INCREASED 35 0.0002
715 LOWER LIMB FRACTURE 3 0.0002
716 ACUTE RESPIRATORY FAILURE 3 0.0002
717 SLEEP DISORDER 11 0.0002
718 ERECTILE DYSFUNCTION 4 0.0002
719 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
720 HERNIA 3 0.0002
721 DYSTONIA 3 0.0002
722 INJECTION SITE INDURATION 2 0.0002
723 PLASMA CELL MYELOMA 6 0.0002
724 AMNESIA 10 0.0002
725 ORAL HERPES 3 0.0002
726 BONE PAIN 9 0.0002
727 KIDNEY INFECTION 3 0.0002
728 MUCOSAL INFLAMMATION 4 0.0002
729 SEDATION 4 0.0002
730 MUSCULOSKELETAL PAIN 8 0.0002
731 JOINT STIFFNESS 4 0.0002
732 OSTEONECROSIS 5 0.0002
733 BEDRIDDEN 2 0.0002
734 IMMUNE SYSTEM DISORDER 2 0.0002
735 DISABILITY 3 0.0002
736 PULMONARY CONGESTION 2 0.0002
737 SINUS DISORDER 3 0.0002
738 HEART RATE INCREASED 15 0.0002
739 HAEMATOCRIT DECREASED 3 0.0002
740 DYSMENORRHOEA 2 0.0002
741 HYPERSENSITIVITY 28 0.0002
742 BRADYCARDIA 8 0.0002
743 VIRAL INFECTION 5 0.0002
744 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001
745 SPINAL FRACTURE 3 0.0001
746 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
747 DRY MOUTH 12 0.0001
748 ANGER 5 0.0001
749 DYSKINESIA 6 0.0001
750 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
751 BLINDNESS 6 0.0001
752 NEUTROPHIL COUNT DECREASED 6 0.0001
753 EPISTAXIS 11 0.0001
754 DRUG TOXICITY 2 0.0001
755 HEADACHE 92 0.0001
756 MOOD ALTERED 4 0.0001
757 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
758 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
759 CONTUSION 14 0.0001
760 DRUG INTOLERANCE 14 0.0001
761 NIGHTMARE 5 0.0001
762 ABDOMINAL DISTENSION 15 0.0001
763 DEVICE OCCLUSION 2 0.0001
764 HYPOXIA 5 0.0001
765 RENAL FAILURE ACUTE 6 0.0001
766 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
767 PAIN IN JAW 4 0.0001
768 ABDOMINAL PAIN UPPER 29 0.0001
769 JOINT INJURY 3 0.0001
770 INTENTIONAL DOSE OMISSION 4 0.0001
771 BRONCHOSPASM 2 0.0001
772 PARALYSIS 2 0.0001
773 ANGINA PECTORIS 4 0.0001
774 HYPERSOMNIA 4 0.0001
775 MYELODYSPLASTIC SYNDROME 2 0.0001
776 VAGINAL HAEMORRHAGE 6 0.0001
777 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
778 FLUID RETENTION 7 0.0001
779 CRYING 5 0.0001
780 RESPIRATORY FAILURE 10 0.0001
781 APATHY 2 0.0001
782 DYSSTASIA 4 0.0001
783 THERAPY CESSATION 7 0.0001
784 APPLICATION SITE PAIN 3 0.0001
785 ASCITES 4 0.0001
786 PSYCHOTIC DISORDER 4 0.0001
787 TACHYCARDIA 12 0.0001
788 PULMONARY MASS 2 0.0001
789 PULMONARY OEDEMA 6 0.0001
790 RASH PAPULAR 3 0.0001
791 SNEEZING 3 0.0001
792 PARAESTHESIA 21 0.0001
793 DYSARTHRIA 5 0.0001
794 ILL-DEFINED DISORDER 8 0.0001
795 PLATELET COUNT DECREASED 14 0.0001
796 VERTIGO 8 0.0001
797 BLOOD PRESSURE INCREASED 20 0.0001
798 PSORIASIS 17 0.0001
799 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
800 VISUAL IMPAIRMENT 16 0.0001
801 CONSTIPATION 28 0.0001
802 MENINGIOMA 2 0.0001
803 CYANOSIS 2 0.0001
804 HAEMATOCHEZIA 7 0.0001
805 DIZZINESS 63 0.0001
806 CYSTITIS 4 0.0001
807 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
808 MOOD SWINGS 4 0.0001
809 ABDOMINAL PAIN 29 0.0001
810 EYE PAIN 7 0.0001
811 FLATULENCE 7 0.0001
812 BLOOD POTASSIUM INCREASED 2 0.0001
813 PRODUCT DOSE OMISSION 8 0.0001
814 AGITATION 9 0.0001
815 ABASIA 3 0.0001
816 INFUSION RELATED REACTION 8 0.0001
817 TREMOR 20 0.0001
818 DRY EYE 6 0.0001
819 MUSCLE SPASMS 22 0.0001
820 URINARY RETENTION 4 0.0001
821 DRY SKIN 16 0.0001
822 CARDIO-RESPIRATORY ARREST 5 0.0001
823 ROAD TRAFFIC ACCIDENT 5 0.0001
824 NAUSEA 94 0.0001
825 CARDIAC DISORDER 11 0.0001
826 HYPOPHAGIA 3 0.0001
827 VISION BLURRED 16 0.0001
828 PARANOIA 2 0.0001
829 RASH GENERALISED 3 0.0001
830 ORTHOSTATIC HYPOTENSION 2 0.0001
831 HYPOTENSION 23 0.0001
832 AMENORRHOEA 2 0.0001
833 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
834 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
835 EXPOSURE DURING PREGNANCY 7 0.0001
836 ISCHAEMIC STROKE 2 0.0001
837 JAUNDICE 3 0.0001
838 PAIN OF SKIN 3 0.0001
839 MOBILITY DECREASED 8 0.0001
840 THERAPY NON-RESPONDER 5 0.0001
841 FREQUENT BOWEL MOVEMENTS 3 0.0001
842 NEUTROPENIA 15 0.0001
843 MEMORY IMPAIRMENT 15 0.0001
844 TREATMENT FAILURE 9 0.0001
845 BLOOD GLUCOSE ABNORMAL 2 0.0001
846 BLOOD CHOLESTEROL INCREASED 5 0.0001
847 MIDDLE INSOMNIA 2 0.0001
848 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
849 RHEUMATOID ARTHRITIS 12 0.0001
850 HYPOCALCAEMIA 2 0.0001
851 PRODUCT DOSE OMISSION ISSUE 31 0.0001
852 DYSPHAGIA 10 0.0001
853 RASH ERYTHEMATOUS 5 0.0001
854 LETHARGY 6 0.0001
855 PULMONARY FIBROSIS 2 0.0001
856 DECREASED APPETITE 24 0.0001
857 MENORRHAGIA 2 0.0001
858 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
859 DISORIENTATION 4 0.0001
860 BLOOD POTASSIUM DECREASED 3 0.0001
861 CYTOKINE RELEASE SYNDROME 2 0.0001
862 PRODUCT ADMINISTRATION ERROR 2 0.0001
863 SUICIDE ATTEMPT 6 0.0001
864 FEEDING DISORDER 2 0.0001
865 PSORIATIC ARTHROPATHY 4 0.0001
866 CHEST DISCOMFORT 10 0.0001
867 INFLUENZA LIKE ILLNESS 8 0.0001
868 LIMB DISCOMFORT 3 0.0001
869 FEMUR FRACTURE 3 0.0001
870 MUSCULAR WEAKNESS 11 0.0001
871 BREAST CANCER 9 0.0001
872 SWOLLEN TONGUE 3 0.0001
873 PULMONARY HYPERTENSION 2 0.0001
874 INTENTIONAL DRUG MISUSE 2 0.0001
875 CONDITION AGGRAVATED 29 0.0001
876 BALANCE DISORDER 8 0.0001
877 SWELLING FACE 6 0.0001
878 PRODUCT PRESCRIBING ISSUE 2 0.0001
879 MYOCARDIAL INFARCTION 16 0.0001
880 TREATMENT NONCOMPLIANCE 5 0.0001
881 MUSCULOSKELETAL STIFFNESS 8 0.0001
882 JOINT SWELLING 11 0.0001
883 MEDICATION ERROR 5 0.0001
884 SYNCOPE 9 0.0001
885 EYE PRURITUS 3 0.0001
886 ADVERSE DRUG REACTION 8 0.0001
887 HYPONATRAEMIA 5 0.0001
888 HAEMATURIA 3 0.0001
889 CARDIAC FAILURE 7 0.0001
890 THROMBOSIS 7 0.0001
891 ADVERSE EVENT 8 0.0001
892 ALOPECIA 17 0.0001
893 PERICARDIAL EFFUSION 2 0.0001
894 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
895 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
896 CEREBROVASCULAR ACCIDENT 14 0.0001
897 MENTAL IMPAIRMENT 2 0.0001
898 STOMATITIS 5 0.0001
899 HYPERGLYCAEMIA 3 0.0001
900 NEURALGIA 2 0.0001
901 RESTLESSNESS 3 0.0001
902 LUNG DISORDER 4 0.0001
903 INJECTION SITE URTICARIA 2 0.0001
904 DYSGEUSIA 6 0.0001
905 HEPATIC FUNCTION ABNORMAL 3 0.0001
906 PNEUMONIA ASPIRATION 2 0.0001
907 INTENTIONAL PRODUCT MISUSE 7 0.0001
908 DYSPNOEA EXERTIONAL 3 0.0001
909 SOMNOLENCE 16 0.0001
910 HAEMATEMESIS 2 0.0001
911 HEPATITIS 2 0.0001
912 HOSPITALISATION 12 0.0001
913 OFF LABEL USE 68 0.0001
914 HYPERHIDROSIS 10 0.0001
915 PALPITATIONS 9 0.0001
916 SUICIDAL IDEATION 7 0.0001
917 DERMATITIS ATOPIC 4 0.0001
918 ABNORMAL BEHAVIOUR 3 0.0001
919 BREAST CANCER FEMALE 2 0.0001
920 ABORTION SPONTANEOUS 3 0.0001
921 PRODUCT USE ISSUE 14 0.0001
922 DISTURBANCE IN ATTENTION 4 0.0001
923 DEVICE BREAKAGE 3 0.0001
924 PALLOR 2 0.0001
925 CARDIAC ARREST 6 0.0001
926 FEELING COLD 2 0.0001
927 HAEMOPTYSIS 2 0.0001
928 BURNING SENSATION 5 0.0001
929 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
930 HYPOACUSIS 3 0.0001
931 EYE IRRITATION 4 0.0001
932 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
933 APHASIA 2 0.0001
934 THERAPEUTIC RESPONSE DECREASED 4 0.0001
935 EPILEPSY 2 0.0001
936 TINNITUS 3 0.0001
937 INJECTION SITE SWELLING 5 0.0001
938 OVERDOSE 14 0.0001
939 BLOOD GLUCOSE INCREASED 12 0.0001
940 COMA 3 0.0001
941 HYPOTHYROIDISM 2 0.0001
942 DRUG INEFFECTIVE 82 0.0001
943 DRUG DEPENDENCE 10 0.0001
944 NIGHT SWEATS 2 0.0001
945 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
946 EYE DISORDER 2 0.0001
947 NEOPLASM MALIGNANT 4 0.0001
948 GAIT INABILITY 2 0.0001
949 SPEECH DISORDER 3 0.0001
950 INCORRECT DOSE ADMINISTERED 13 0.0001
951 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
952 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
953 SKIN BURNING SENSATION 4 0.0001
954 DEATH 48 0.0001
955 MYELOSUPPRESSION 2 0.0001
956 LOSS OF CONSCIOUSNESS 7 0.0001
957 CONVULSION 3 0.0001
958 INJECTION SITE PAIN 16 0.0001
959 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
960 FEELING ABNORMAL 12 0.0001
961 EXTRA DOSE ADMINISTERED 2 0.0000
962 FEELING HOT 3 0.0000
963 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
964 INJECTION SITE ERYTHEMA 6 0.0000
965 DRUG ABUSE 4 0.0000
966 POLLAKIURIA 2 0.0000
967 INTENTIONAL OVERDOSE 3 0.0000
968 DEVICE EXPULSION 3 0.0000
969 INJECTION SITE PRURITUS 3 0.0000
970 NO ADVERSE EVENT 8 0.0000
971 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
972 SEIZURE 5 0.0000
973 DISEASE RECURRENCE 2 0.0000
974 MULTIPLE SCLEROSIS 2 0.0000
975 BLOOD GLUCOSE DECREASED 2 0.0000
976 INTERSTITIAL LUNG DISEASE 2 0.0000
977 HYPOGLYCAEMIA 2 0.0000
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
979 FLUSHING 4 0.0000
980 HAEMORRHAGE 4 0.0000
981 INJECTION SITE HAEMORRHAGE 3 0.0000
982 TOXICITY TO VARIOUS AGENTS 6 0.0000
983 PRODUCT STORAGE ERROR 3 0.0000
984 IRRITABILITY 2 0.0000
985 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
986 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
988 DISEASE PROGRESSION 3 0.0000
989 DRUG DOSE OMISSION 4 0.0000
990 COMPLETED SUICIDE 2 0.0000
991 DRUG WITHDRAWAL SYNDROME 2 0.0000
992 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
993 PRODUCT QUALITY ISSUE 3 0.0000